MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Havlickova, M.
Right arrow Articles by Blahos, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Havlickova, M.
Right arrow Articles by Blahos, J.

Vol. 62, Issue 2, 343-350, August 2002

The Intracellular Loops of the GB2 Subunit Are Crucial for G-Protein Coupling of the Heteromeric gamma -Aminobutyrate B Receptor

Michaela Havlickova, Laurent Prezeau, Beatrice Duthey, Bernhard Bettler, Jean-Philippe Pin, and Jaroslav Blahos

Department of Molecular Pharmacology, Institute of Experimental Medicine, Czech Academy of Science, Prague, Czech Republic (M.H., J.B.); Mécanismes Moléculaires des Communications Cellulaires, Montpellier, France (M.H., L.P., B.D., J.-P.P.); and Pharmacenter, University of Basel, Basel, Switzerland (B.B.)

The gamma -aminobutyrate B (GABAB) receptor is the first discovered G-protein-coupled receptor (GPCR) that needs two subunits, GB1 and GB2, to form a functional receptor. The GB1 extracellular domain (ECD) binds GABA, and GB2 contains enough molecular determinants for G-protein activation. The precise role of the two subunits in G-protein coupling is investigated. GB1 and GB2 are structurally related to the metabotropic glutamate, Ca2+-sensing and other family 3 GPCRs in which the second (i2) as well as the third (i3) intracellular loop play important roles in G-protein coupling. Here, the role of the i2 loops of GB1 and GB2 in the GABAB receptor ability to activate Galpha -proteins is investigated. To that aim, the i2 loops were swapped between GB1 and GB2 heptahelical domains (HDs), either in the wild-type subunits or in the chimeric subunits GB1/2 that contain the ECD of GB1 and the HD of GB2. The effect of an additional mutation within the i3 loop of GB2 that prevents coupling of the heteromeric receptor was also examined. Combinations of interest were found to be correctly addressed at the cell surface and to assemble into heteromers. Taken together our data revealed the following new information on the G-protein coupling of the heteromeric GABAB receptor: 1) the i2 loop of GB2 within the GB2 HD is required for the heteromeric GABAB receptor to couple to G-proteins, whereas the i2 loop of GB1 is not; 2) the presence of the i2 loop of GB2 within the GB1 HD is not sufficient to allow coupling of GB1; 3) the GB2 HD activates the Gqi9 protein whether it is associated with the GB2 or GB1 ECD; 4) in the combination with two GB2 HDs, each is able to couple to G-proteins; and finally, 5) the use of mutations in i2, i3, or both within the GB2 HD brings evidence for the absence of domain swapping enabling the exchange of region including i2 and i3 between the subunits.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Balasubramanian, S. R. Fam, and R. A. Hall
GABAB Receptor Association with the PDZ Scaffold Mupp1 Alters Receptor Stability and Function
J. Biol. Chem., February 9, 2007; 282(6): 4162 - 4171.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Mukherjee, E. W. McBride, M. Beinborn, K. Dunlap, and A. S. Kopin
Point Mutations in Either Subunit of the GABAB Receptor Confer Constitutive Activity to the Heterodimer
Mol. Pharmacol., October 1, 2006; 70(4): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Uezono, M. Kanaide, M. Kaibara, R. Barzilai, N. Dascal, K. Sumikawa, and K. Taniyama
Coupling of GABAB receptor GABAB2 subunit to G proteins: evidence from Xenopus oocyte and baby hamster kidney cell expression system
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C200 - C207.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
M. C. Overton, S. L. Chinault, and K. J. Blumer
Oligomerization of G-Protein-Coupled Receptors: Lessons from the Yeast Saccharomyces cerevisiae
Eukaryot. Cell, December 1, 2005; 4(12): 1963 - 1970.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch
From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation
PNAS, November 29, 2005; 102(48): 17495 - 17500.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Gassmann, C. Haller, Y. Stoll, S. A. Aziz, B. Biermann, J. Mosbacher, K. Kaupmann, and B. Bettler
The RXR-Type Endoplasmic Reticulum-Retention/Retrieval Signal of GABAB1 Requires Distant Spacing from the Membrane to Function
Mol. Pharmacol., July 1, 2005; 68(1): 137 - 144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Javitch
The Ants Go Marching Two by Two: Oligomeric Structure of G-Protein-Coupled Receptors
Mol. Pharmacol., November 1, 2004; 66(5): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Binet, C. Brajon, L. Le Corre, F. Acher, J.-P. Pin, and L. Prezeau
The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor
J. Biol. Chem., July 9, 2004; 279(28): 29085 - 29091.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Gassmann, H. Shaban, R. Vigot, G. Sansig, C. Haller, S. Barbieri, Y. Humeau, V. Schuler, M. Muller, B. Kinzel, et al.
Redistribution of GABAB(1) Protein and Atypical GABAB Responses in GABAB(2)-Deficient Mice
J. Neurosci., July 7, 2004; 24(27): 6086 - 6097.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Yin, S. Gavi, H.-y. Wang, and C. C. Malbon
Probing Receptor Structure/Function with Chimeric G-Protein-Coupled Receptors
Mol. Pharmacol., June 1, 2004; 65(6): 1323 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Liu, D. Maurel, S. Etzol, I. Brabet, H. Ansanay, J.-P. Pin, and P. Rondard
Molecular Determinants Involved in the Allosteric Control of Agonist Affinity in the GABAB Receptor by the GABAB2 Subunit
J. Biol. Chem., April 16, 2004; 279(16): 15824 - 15830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Chinault, M. C. Overton, and K. J. Blumer
Subunits of a Yeast Oligomeric G Protein-coupled Receptor Are Activated Independently by Agonist but Function in Concert to Activate G Protein Heterotrimers
J. Biol. Chem., April 16, 2004; 279(16): 16091 - 16100.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Terrillon, T. Durroux, B. Mouillac, A. Breit, M. A. Ayoub, M. Taulan, R. Jockers, C. Barberis, and M. Bouvier
Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis
Mol. Endocrinol., April 1, 2003; 17(4): 677 - 691.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Guo, L. Shi, and J. A. Javitch
The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer
J. Biol. Chem., February 7, 2003; 278(7): 4385 - 4388.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Kniazeff, T. Galvez, G. Labesse, and J.-P. Pin
No Ligand Binding in the GB2 Subunit of the GABAB Receptor Is Required for Activation and Allosteric Interaction between the Subunits
J. Neurosci., September 1, 2002; 22(17): 7352 - 7361.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics